CAS 1802086-25-4

Gastric Inhibitory Polypeptide (3-42) (human)

CAS : 1802086-25-4

Gastric inhibitory polypeptide (3-42) represents the major physiological degradation product of gastric inhibitory polypeptide (GIP). It is generated by proteolytic processing of GIP by dipeptidyl peptidase IV (DPP IV).

Formule : C₂₁₄H₃₂₄N₅₈O₆₃S

Degré de pureté : 96.1%

Couleur et forme : White Powder

Masse moléculaire : 4749.35

Ref: 01-4034653

GIP (3-42), human

CAS : 1802086-25-4

Human GIP (3-42) is a peptide antagonist of GIP receptors, affecting insulin regulation and diabetes research.

Formule : C₂₁₄H₃₂₄N₅₈O₆₃S

Degré de pureté : 95.73%

Couleur et forme : Solid

Masse moléculaire : 4749.35

Ref: TM-T37589

GIP (3 - 42), human

CAS : 1802086-25-4

Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool

Formule : C₂₁₄H₃₂₄N₅₈O₆₃S

Masse moléculaire : 4,749.38 g/mol

Ref: 3D-PP50414

Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt

CAS : 1802086-25-4

Please enquire for more information about Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formule : C₂₁₄H₃₂₄N₅₈O₆₃S

Degré de pureté : Min. 95%

Masse moléculaire : 4,749.28 g/mol

Ref: 3D-FG109902